ATPergic signalling during seizures and epilepsy. (May 2016)

• Record Type: Journal Article
• Authors: Engel, Tobias; Alves, Mariana; Sheedy, Caroline; Henshall, David C.
• Is Part Of: Neuropharmacology. Volume 104(2016)
• Page Start: 140
• Page End: 153
• Publication Date: 2016-05
• Subjects: Epilepsy -- Seizures -- Status epilepticus -- ATP -- P2 purinergic receptors; AED anti-epileptic drug -- BBG brilliant blue G -- EEG electroencephalogram -- GABA γ-aminobutyric acid -- Il-1β Interleukin-1β -- P2 purinergic receptor -- SE status epilepticus -- TLE temporal lobe epilepsy; Neuropsychopharmacology -- Periodicals; Autonomic Agents -- Periodicals; Neuropsychopharmacologie -- Périodiques; Neuropsychopharmacology; Periodicals; Electronic journals; 615.78
• DOI: 10.1016/j.neuropharm.2015.11.001
• Languages: English
• ISSNs: 0028-3908

Abstract

Abstract: Much progress has been made over the last few decades in the identification of new anti-epileptic drugs (AEDs). However, 30% of epilepsy patients suffer poor seizure control. This underscores the need to identify alternative druggable neurotransmitter systems and drugs with novel mechanisms of action. An emerging concept is that seizure generation involves a complex interplay between neurons and glial cells at the tripartite synapse and neuroinflammation has been proposed as one of the main drivers of epileptogenesis. The ATP-gated purinergic receptor family is expressed throughout the brain and is functional on neurons and glial cells. ATP is released in high amounts into the extracellular space after increased neuronal activity and during chronic inflammation and cell death to act as a neuro- and gliotransmitter. Emerging work shows pharmacological targeting of ATP-gated purinergic P2 receptors can potently modulate seizure generation, inflammatory processes and seizure-induced brain damage. To date, work showing the functional contribution of P2 receptors has been mainly performed in animal models of acute seizures, in particular, by targeting the ionotropic P2X7 receptor subtype. Other ionotropic P2X and metabotropic P2Y receptor family members have also been implicated in pathological processes following seizures such as the P2X4 receptor and the P2Y12 receptor. However, during epilepsy, the characterization of P2 receptors was mostly restricted to the study of expressional changes of the different receptor subtypes. This review summarizes the work to date on ATP-mediated signalling during seizures and the functional impact of targeting the ATP-gated purinergic receptors on seizures and seizure-induced pathology. This article is part of the Special Issue entitled 'Purines in Neurodegeneration and Neuroregeneration'. Highlights: 30% of epilepsy patients remain drug-refractory. Increased hyperexcitability states may be caused by a sustained glial activation. ATP-gated receptors may act as a possible link between inflammation and hyperexcitability. Mounting data demonstrates ATP signalling involvement in seizure generation.